The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage
Open accessAbstract
Aneurysmal subarachnoid hemorrhage (SAH) is a sub-type of hemorrhagic stroke associated with the highest rates of mortality and long-term neurological disabilities. Despite the improvement in the management of SAH patients and the reduction in case fatality in the last decades, disability and mortality remain high in this population. Brain injury can occur immediately and in the first days after SAH. This early brain injury can be due to physical effects on the brain such as increased intracranial pressure, herniations, intracerebral, intraventricular hemorrhage, and hydrocephalus. After the first 3 days, angiographic cerebral vasospasm (ACV) is a common neurological complication that in severe cases can lead to delayed cerebral ischemia and cerebral infarction. Consequently, the prevention and treatment of ACV continue to be a major goal. However, most treatments for ACV are vasodilators since ACV is due to arterial vasoconstriction. Other targets also have included those directed at the underlying biochemical mechanisms of brain injury such as inflammation and either independently or as a consequence, cerebral microthrombosis, cortical spreading ischemia, blood-brain barrier breakdown, and cerebral ischemia. Unfortunately, no pharmacologic treatment directed at these processes has yet shown efficacy in SAH. Enteral nimodipine and the endovascular treatment of the culprit aneurysm, remain the only treatment options supported by evidence from randomized clinical trials to improve patients' outcome. Currently, there is no intervention directly developed and approved to target neuroinflammation after SAH. The goal of this review is to provide an overview on anti-inflammatory drugs tested after aneurysmal SAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Suwatcharangkoon, S., Meyers, E., Falo, C., Schmidt, J. M., Agarwal, S., Claassen, J., & Mayer, S. A. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.3188 · Cited by 114
Cited by
Hoh, B. L., Ko, N. U., Amin-Hanjani, S., Chou, S. H.-Y., Cruz-Flores, S., Dangayach, N. S., Derdeyn, C. P., Du, R., Hänggi, D., Hetts, S. W., et al. (2023) · Stroke · doi:10.1161/str.0000000000000436 · Cited by 1,000
Spontaneous subarachnoid haemorrhage
Claassen, J., & Park, S. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00938-2 · Cited by 587
Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review
Dodd, W. S., Laurent, D., Dumont, A. S., Hasan, D. M., Jabbour, P. M., Starke, R. M., Hosaka, K., Polifka, A. J., Hoh, B. L., & Chalouhi, N. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021845 · Cited by 315
Early Brain Injury After Poor-Grade Subarachnoid Hemorrhage
Rass, V., & Helbok, R. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0990-3 · Cited by 253
Meningeal lymphatics clear erythrocytes that arise from subarachnoid hemorrhage.
Chen, J., Wang, L., Xu, H., Xing, L., Zhuang, Z., Zheng, Y., Li, X., Wang, C., Chen, S., Guo, Z., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16851-z · Cited by 208
Metadata
- Authors
- de Oliveira Manoel, A. L., & Macdonald, R. L.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2018-05-02
- Volume
- 9
- Pages
- 292-292
- ISSN
- 1664-2295 (ISSN-L)
- OpenAlex
- W2799386458
- Cited by
- 169
- References
- 1
- FWCI
- 13.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage. https://app.cochat.ai/papers/10.3389/fneur.2018.00292
- The paper
- de Oliveira Manoel, A. L., & Macdonald, R. L. (2018). Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage. Frontiers in Neurology. https://doi.org/10.3389/fneur.2018.00292
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.